Solomon Woldu
Associate Professor · University of Texas Southwestern Medical Center
Credentials: · · ·
History
2002–2006
Research
Guideline of guidelines: non-muscle-invasive bladder cancer
Review · BJU international · 2017 · First of 3 authors · 226 citations
Mitochondrial complex I promotes kidney cancer metastasis
Nature · 2024 · 116 citations
Seminars in Urologic Oncology · 2020 · Last of 11 authors · Corresponding · 115 citations
89 papers
80 papers
66 papers · 3 as a resident
41 papers · 38 as a resident
23 papers · 13 as a resident
20 papers · 4 as a fellow
- YF
18 papers · 18 as a resident
- RG
17 papers · 15 as a fellow
Clinical trials
- 2023–2028
Principal investigator · Recruiting
UroGen Pharma Ltd.
- 2021–2023
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
Principal investigator · Terminated
University of Texas Southwestern Medical Center
- 2024–2027
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Site PI · Recruiting · Phase 2
CG Oncology, Inc.
- 2024–2026
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Site PI · Recruiting
University of Texas Southwestern Medical Center